Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

No excess risk of adverse pregnancy outcomes among women with serological markers of previous infection with Coxiella burnetii: evidence from the Danish National Birth Cohort

Authors: Stine Yde Nielsen, Anne-Marie Nybo Andersen, Kåre Mølbak, Niels Henrik Hjøllund, Bjørn Kantsø, Karen Angeliki Krogfelt, Tine Brink Henriksen

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Q fever caused by Coxiella burnetii is transmitted to humans by inhalation of aerosols from animal birth products. Q fever in pregnancy is suspected to be a potential cause of fetal and maternal morbidity and fetal mortality but the pathogenesis is poorly understood, and even in Q fever endemic areas, the magnitude of a potential association is not established.
We aimed to examine if presence of antibodies to C. burnetii during pregnancy or seroconversion were associated with adverse pregnancy outcomes.

Methods

The Danish National Birth Cohort collected blood samples and interview data from 100,418 pregnant women (1996–2002). We sampled 397 pregnant women with occupational or domestic exposure to cattle or sheep and a random sample of 459 women with no animal exposure. Outcome measures were spontaneous abortion, preterm birth, birth weight and Small for Gestational Age (SGA).
Blood samples collected in pregnancy were screened for antibodies against C. burnetii by enzyme-linked immunosorbent assay (ELISA). Samples positive for IgG or IgM antibodies in the ELISA were confirmed by immunofluorescence antibody test (IFA).

Results

Among the 856 women, 169 (19.7%) women were IFA positive; 147 (87%) of these had occupational or domestic contact with livestock (IFA cutoff > =1:128).
Two abortions were IFA positive vs. 6 IFA negative (OR: 1.5; 95%CI: 0.3-7.6). Three preterm births were IFA positive vs. 38 IFA negative (OR: 0.4; 95% CI: 0.1-1.1). There was a significant difference in birth weight of 168 g (95% CI: 70-267 g) with IFA positive being heavier, and the risk of being SGA was not increased in the newborns of IFA positive women (OR: 0.4; 95%CI: 0.8-1.0).
Most seropositive women were IgG positive indicating previous exposure. Seroconversion during pregnancy was found in 10 women; they all delivered live babies at term, but two were SGA.

Conclusion

We found no increased risk of adverse pregnancy outcome in women with verified exposure to C. burnetii.
To our knowledge, this is the first population-based seroepidemiologic study evaluating pregnancy outcome in women with serologically verified exposure to C. burnetii against a comparable reference group of seronegative women.
Literature
1.
go back to reference Berri M, Rousset E, Champion JL, Russo P, Rodolakis A: Goats may experience reproductive failures and shed coxiella burnetii at two successive parturitions after a Q fever infection. Res Vet Sci. 2007, 83 (1): 47-52. 10.1016/j.rvsc.2006.11.001.CrossRefPubMed Berri M, Rousset E, Champion JL, Russo P, Rodolakis A: Goats may experience reproductive failures and shed coxiella burnetii at two successive parturitions after a Q fever infection. Res Vet Sci. 2007, 83 (1): 47-52. 10.1016/j.rvsc.2006.11.001.CrossRefPubMed
2.
go back to reference Bildfell RJ, Thomson GW, Haines DM, McEwen BJ, Smart N: Coxiella burnetii infection is associated with placentitis in cases of bovine abortion. J Vet Diagn Invest. 2000, 12 (5): 419-425. 10.1177/104063870001200505.CrossRefPubMed Bildfell RJ, Thomson GW, Haines DM, McEwen BJ, Smart N: Coxiella burnetii infection is associated with placentitis in cases of bovine abortion. J Vet Diagn Invest. 2000, 12 (5): 419-425. 10.1177/104063870001200505.CrossRefPubMed
4.
go back to reference Parker NR, Barralet JH, Bell AM: Q fever. Lancet. 2006, 367 (9511): 679-688. 10.1016/S0140-6736(06)68266-4.CrossRefPubMed Parker NR, Barralet JH, Bell AM: Q fever. Lancet. 2006, 367 (9511): 679-688. 10.1016/S0140-6736(06)68266-4.CrossRefPubMed
5.
go back to reference Tissot-Dupont H, Vaillant V, Rey S, Raoult D: Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis. 2007, 44 (2): 232-237. 10.1086/510389.CrossRefPubMed Tissot-Dupont H, Vaillant V, Rey S, Raoult D: Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis. 2007, 44 (2): 232-237. 10.1086/510389.CrossRefPubMed
6.
go back to reference Agger JF, Christoffersen AB, Rattenborg E, Nielsen J, Agerholm JS: Prevalence of coxiella burnetii antibodies in Danish dairy herds. Acta Vet Scand. 2010, 52: 5-10.1186/1751-0147-52-5.CrossRefPubMedPubMedCentral Agger JF, Christoffersen AB, Rattenborg E, Nielsen J, Agerholm JS: Prevalence of coxiella burnetii antibodies in Danish dairy herds. Acta Vet Scand. 2010, 52: 5-10.1186/1751-0147-52-5.CrossRefPubMedPubMedCentral
7.
go back to reference Bacci S, Villumsen S, Valentiner-Branth P, Smith B, Krogfelt KA, Molbak K: Epidemiology and clinical features of human infection with coxiella burnetii in Denmark during 2006–07. Zoonoses Public Health. 2011, 59 (1): 61-68.CrossRefPubMed Bacci S, Villumsen S, Valentiner-Branth P, Smith B, Krogfelt KA, Molbak K: Epidemiology and clinical features of human infection with coxiella burnetii in Denmark during 2006–07. Zoonoses Public Health. 2011, 59 (1): 61-68.CrossRefPubMed
8.
go back to reference Bosnjak E, Hvass AM, Villumsen S, Nielsen H: Emerging evidence for Q fever in humans in Denmark: role of contact with dairy cattle. Clin Microbiol Infect. 2010, 16 (8): 1285-1288.CrossRefPubMed Bosnjak E, Hvass AM, Villumsen S, Nielsen H: Emerging evidence for Q fever in humans in Denmark: role of contact with dairy cattle. Clin Microbiol Infect. 2010, 16 (8): 1285-1288.CrossRefPubMed
9.
go back to reference Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A: Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis. 2007, 45 (5): 548-555. 10.1086/520661.CrossRefPubMed Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A: Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis. 2007, 45 (5): 548-555. 10.1086/520661.CrossRefPubMed
10.
go back to reference Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A: Q fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci. 2009, 1166: 79-89. 10.1111/j.1749-6632.2009.04519.x.CrossRefPubMed Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A: Q fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci. 2009, 1166: 79-89. 10.1111/j.1749-6632.2009.04519.x.CrossRefPubMed
11.
go back to reference Raoult D, Fenollar F, Stein A: Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med. 2002, 162 (6): 701-704. 10.1001/archinte.162.6.701.CrossRefPubMed Raoult D, Fenollar F, Stein A: Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med. 2002, 162 (6): 701-704. 10.1001/archinte.162.6.701.CrossRefPubMed
12.
go back to reference Munster JM: Effectivenss of a screening program for Q fever during pregnancy: a clustered randomised controlled trial. 2011, Stockholm: Presentantion at the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE), abstract Munster JM: Effectivenss of a screening program for Q fever during pregnancy: a clustered randomised controlled trial. 2011, Stockholm: Presentantion at the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE), abstract
13.
go back to reference van der Hoek W, Meekelenkamp JC, Leenders AC, Wijers N, Notermans DW, Hukkelhoven CW: Antibodies against coxiella burnetii and pregnancy outcome during the 2007–2008 Q fever outbreaks in the Netherlands. BMC Infect Dis. 2011, 11: 44-10.1186/1471-2334-11-44.CrossRefPubMedPubMedCentral van der Hoek W, Meekelenkamp JC, Leenders AC, Wijers N, Notermans DW, Hukkelhoven CW: Antibodies against coxiella burnetii and pregnancy outcome during the 2007–2008 Q fever outbreaks in the Netherlands. BMC Infect Dis. 2011, 11: 44-10.1186/1471-2334-11-44.CrossRefPubMedPubMedCentral
14.
go back to reference Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, Taxbol D, Hansen KD, Juhl M, Schow TB, Sorensen HT, Andresen J, Mortensen EL, Olesen AW, Sondergaard C: The danish national birth cohort–its background, structure and aim. Scand J Public Health. 2001, 29 (4): 300-307.CrossRefPubMed Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, Taxbol D, Hansen KD, Juhl M, Schow TB, Sorensen HT, Andresen J, Mortensen EL, Olesen AW, Sondergaard C: The danish national birth cohort–its background, structure and aim. Scand J Public Health. 2001, 29 (4): 300-307.CrossRefPubMed
15.
go back to reference Marmion BP, Storm PA, Ayres JG, Semendric L, Mathews L, Winslow W, Turra M, Harris RJ: Long-term persistence of coxiella burnetii after acute primary Q fever. QJM. 2005, 98 (1): 7-20. 10.1093/qjmed/hci009.CrossRefPubMed Marmion BP, Storm PA, Ayres JG, Semendric L, Mathews L, Winslow W, Turra M, Harris RJ: Long-term persistence of coxiella burnetii after acute primary Q fever. QJM. 2005, 98 (1): 7-20. 10.1093/qjmed/hci009.CrossRefPubMed
16.
go back to reference Villumsen S, Jorgensen CS, Smith B, Uldum S, Schiellerup P, Krogfelt KA: Determination of new cutoff values for indirect immunofluorescence antibody test for Q fever diagnosis in Denmark. Diagn Microbiol Infect Dis. 2009, 65 (2): 93-98. 10.1016/j.diagmicrobio.2009.06.004.CrossRefPubMed Villumsen S, Jorgensen CS, Smith B, Uldum S, Schiellerup P, Krogfelt KA: Determination of new cutoff values for indirect immunofluorescence antibody test for Q fever diagnosis in Denmark. Diagn Microbiol Infect Dis. 2009, 65 (2): 93-98. 10.1016/j.diagmicrobio.2009.06.004.CrossRefPubMed
17.
go back to reference Field PR, Mitchell JL, Santiago A, Dickeson DJ, Chan SW, Ho DW, Murphy AM, Cuzzubbo AJ, Devine PL: Comparison of a commercial enzyme-linked immunosorbent assay with immunofluorescence and complement fixation tests for detection of coxiella burnetii (Q fever) immunoglobulin M. J Clin Microbiol. 2000, 38 (4): 1645-1647.PubMedPubMedCentral Field PR, Mitchell JL, Santiago A, Dickeson DJ, Chan SW, Ho DW, Murphy AM, Cuzzubbo AJ, Devine PL: Comparison of a commercial enzyme-linked immunosorbent assay with immunofluorescence and complement fixation tests for detection of coxiella burnetii (Q fever) immunoglobulin M. J Clin Microbiol. 2000, 38 (4): 1645-1647.PubMedPubMedCentral
18.
go back to reference Kantso B, Svendsen CB, Jorgensen CS, Krogfelt KA: Comparison of two commercially available ELISA antibody test kits for detection of human antibodies against coxiella burnetii. Scand J Infect Dis. 2012, 44 (7): 489-494. 10.3109/00365548.2012.664777.CrossRefPubMed Kantso B, Svendsen CB, Jorgensen CS, Krogfelt KA: Comparison of two commercially available ELISA antibody test kits for detection of human antibodies against coxiella burnetii. Scand J Infect Dis. 2012, 44 (7): 489-494. 10.3109/00365548.2012.664777.CrossRefPubMed
19.
go back to reference Field PR, Santiago A, Chan SW, Patel DB, Dickeson D, Mitchell JL, Devine PL, Murphy AM: Evaluation of a novel commercial enzyme-linked immunosorbent assay detecting coxiella burnetii-specific immunoglobulin G for Q fever prevaccination screening and diagnosis. J Clin Microbiol. 2002, 40 (9): 3526-3529. 10.1128/JCM.40.9.3526-3529.2002.CrossRefPubMedPubMedCentral Field PR, Santiago A, Chan SW, Patel DB, Dickeson D, Mitchell JL, Devine PL, Murphy AM: Evaluation of a novel commercial enzyme-linked immunosorbent assay detecting coxiella burnetii-specific immunoglobulin G for Q fever prevaccination screening and diagnosis. J Clin Microbiol. 2002, 40 (9): 3526-3529. 10.1128/JCM.40.9.3526-3529.2002.CrossRefPubMedPubMedCentral
21.
go back to reference Nielsen SY, Hjollund NH, Andersen AM, Henriksen TB, Kantso B, Krogfelt KA, Molbak K: Presence of antibodies against coxiella burnetii and risk of spontaneous abortion: a nested case–control study. PLoS One. 2012, 7 (2): e31909-10.1371/journal.pone.0031909.CrossRefPubMedPubMedCentral Nielsen SY, Hjollund NH, Andersen AM, Henriksen TB, Kantso B, Krogfelt KA, Molbak K: Presence of antibodies against coxiella burnetii and risk of spontaneous abortion: a nested case–control study. PLoS One. 2012, 7 (2): e31909-10.1371/journal.pone.0031909.CrossRefPubMedPubMedCentral
22.
go back to reference Whitney EA, Massung RF, Candee AJ, Ailes EC, Myers LM, Patterson NE, Berkelman RL: Seroepidemiologic and occupational risk survey for coxiella burnetii antibodies among US veterinarians. Clin Infect Dis. 2009, 48 (5): 550-557. 10.1086/596705.CrossRefPubMed Whitney EA, Massung RF, Candee AJ, Ailes EC, Myers LM, Patterson NE, Berkelman RL: Seroepidemiologic and occupational risk survey for coxiella burnetii antibodies among US veterinarians. Clin Infect Dis. 2009, 48 (5): 550-557. 10.1086/596705.CrossRefPubMed
23.
go back to reference Angelakis E, Million M, D’Amato F, Rouli L, Richet H, Stein A, Rolain JM, Raoult D: Q fever and pregnancy: disease, prevention, and strain specificity. Eur J Clin Microbiol Infect Dis. 2012, 32 (3): 361-368.CrossRefPubMed Angelakis E, Million M, D’Amato F, Rouli L, Richet H, Stein A, Rolain JM, Raoult D: Q fever and pregnancy: disease, prevention, and strain specificity. Eur J Clin Microbiol Infect Dis. 2012, 32 (3): 361-368.CrossRefPubMed
24.
go back to reference Boden K, Brueckmann A, Wagner-Wiening C, Hermann B, Henning K, Junghanss T, Seidel T, Baier M, Straube E, Theegarten D: Maternofetal consequences of coxiella burnetii infection in pregnancy: a case series of two outbreaks. BMC Infect Dis. 2012, 12 (1): 359-10.1186/1471-2334-12-359.CrossRefPubMedPubMedCentral Boden K, Brueckmann A, Wagner-Wiening C, Hermann B, Henning K, Junghanss T, Seidel T, Baier M, Straube E, Theegarten D: Maternofetal consequences of coxiella burnetii infection in pregnancy: a case series of two outbreaks. BMC Infect Dis. 2012, 12 (1): 359-10.1186/1471-2334-12-359.CrossRefPubMedPubMedCentral
25.
go back to reference van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, ter Schegget R, Hackert V, van Duynhoven Y: Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 2010, 15 (12): 19520-PubMed van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, ter Schegget R, Hackert V, van Duynhoven Y: Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 2010, 15 (12): 19520-PubMed
Metadata
Title
No excess risk of adverse pregnancy outcomes among women with serological markers of previous infection with Coxiella burnetii: evidence from the Danish National Birth Cohort
Authors
Stine Yde Nielsen
Anne-Marie Nybo Andersen
Kåre Mølbak
Niels Henrik Hjøllund
Bjørn Kantsø
Karen Angeliki Krogfelt
Tine Brink Henriksen
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-87

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine